To investigate the association of CHST11 overexpression with tumor progression, we interrogated another dataset in the Oncomine database, comparing the expression of CHST11 between ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) (30). Here, CHST11 is linked to invasive ductal breast carcinoma.